PAVmed Inc.

NASDAQ:PAVM

0.6561 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 0.9960.9791.011.0490.7910.1660.4460.1120.07600.1890.30.200000000000000000000000000
Cost of Revenue 1.3811.9712.332.3361.7791.6851.3461.6181.6260.8150.3690.4410.1440.0160.012000000000000000001.350.960.5180000
Gross Profit -0.385-0.992-1.32-1.287-0.988-1.519-0.9-1.506-1.55-0.815-0.18-0.1410.056-0.016-0.01200000000000000000-1.35-0.96-0.5180000
Gross Profit Ratio -0.387-1.013-1.307-1.227-1.249-9.151-2.018-13.446-20.3950-0.952-0.470.2800000000000000000000000000
Reseach & Development Expenses 1.5421.6411.9413.5953.1613.4694.4396.6746.2026.745.9326.9695.3054.2583.3153.6422.6192.1332.6282.2551.5191.4051.4511.3711.1711.1480.5630.5550.7050.7020.6570.6070.5780.3550.1790.1410.2650.0670.016
General & Administrative Expenses 6.6497.0096.6787.0316.8587.10710.01810.05910.3211.8399.4239.4665.9876.7393.3753.9142.9092.8812.6252.3341.7241.9141.6931.9411.3981.5911.3811.3331.2631.321.51.1041.350.960.5180.5890.2740.2930.13
Selling & Marketing Expenses 2.924.2424.3114.694.0163.8844.5395.7594.7364.8983.9258.8952.2931.8751.3871.2570.6870.460.38500000000000000000000
SG&A 9.56911.25110.77511.50110.87410.99114.55715.81815.05616.73713.34818.3615.9876.7394.7623.9142.9092.8812.6252.3341.7241.9141.6931.9411.3981.5911.3811.3331.2631.321.51.1041.350.960.5180.5890.2740.2930.13
Other Expenses 0.082-0.23725.7720.505-0.340.5050.5060.505-5.101-0.173-6.0872.4321.9731.6825.5210.3672.12-8.008-0.2180.379-0.161-0.55900003.12400-3.12400000000
Operating Expenses 11.19312.69212.71615.09614.5414.96519.50122.99821.76323.47719.2819.53813.72412.978.0777.5565.5285.0145.2534.5893.2443.3193.1443.3122.5692.7391.9441.8881.9682.0212.1561.7111.9291.3150.6970.7310.5390.3610.146
Operating Income -11.578-13.684-14.036-16.383-15.528-16.484-20.401-24.504-23.313-23.477-19.46-19.679-13.668-12.97-8.077-7.556-5.528-5.014-5.253-4.589-3.244-3.319-3.144-3.312-2.569-2.739-1.944-1.888-1.968-2.021-2.156-1.711-1.929-1.315-0.697-0.731-0.539-0.361-0.146
Operating Income Ratio -11.624-13.978-13.897-15.618-19.631-99.301-45.742-218.786-306.750-102.963-65.597-68.3400000000000000000000000000
Total Other Income Expenses Net 72.289-1.23-4.476-1.025-6.222-1.408-1.813-0.068-6.565-5.6170.002000.3-2.033-1.703-0.346-0.83-9.658-1.965-0.028-0.42-0.56-3.61-0.71-2.408-0.8822.758-3.1611.032-2.11400000000
Income Before Tax 60.711-14.914-18.512-17.408-21.75-17.892-22.214-24.572-29.932-29.101-19.633-19.679-13.668-12.67-10.11-9.259-5.874-5.844-14.911-6.554-3.271-3.739-3.704-6.922-3.279-5.147-2.8250.87-5.129-0.99-4.27-1.711-1.929-1.315-0.697-0.731-0.539-0.361-0.146
Income Before Tax Ratio 60.955-15.234-18.329-16.595-27.497-107.783-49.807-219.393-393.8420-103.878-65.597-68.3400000000000000000000000000
Income Tax Expense 004,276-3.372-4.002-3,280-4,209-4.044-3.806-3.576-2.761-2.461-1.441-1.199-0.679-0.519-0.391-0.266-0.436-0.31-0.186-0.146-0.169-0.09-0.032-0.0810.5890.3630.2410.0510.026-5.651000-0.731-0.539-0.361-0.146
Net Income 64.399-10.827-15.212-14.036-17.748-14.5374,186.786-20.528-26.126-25.525-16.872-17.218-12.227-11.471-9.431-8.74-5.483-5.578-14.475-6.244-3.085-3.594-3.535-6.832-3.246-5.065-2.8250.87-5.129-0.99-4.27-1.711-1.929-1.315-0.697-0.731-0.539-0.361-0.146
Net Income Ratio 64.658-11.059-15.061-13.38-22.437-87.5729,387.413-183.286-343.7630-89.27-57.393-61.13500000000000000000000000000
EPS 6.43-1.19-2.62-1.98-2.38-2.1-2.78-3.31-4.38-4.42-2.94-3-2.21-2.11-1.93-2.49-1.72-1.89-5.02-2.86-1.52-1.99-1.99-3.89-1.87-3.99-3.10.33-6.04-1.17-4.83-1.93-2.17-1.52-0.85-0.89-0.73-0.5-0.2
EPS Diluted 1.45-1.19-2.62-1.98-2.38-2.1-2.78-3.31-4.38-4.42-2.94-3-2.21-2.11-1.93-2.49-1.72-1.89-5.02-2.86-1.52-1.99-1.99-3.89-1.87-3.99-3.10.33-6.04-1.17-4.83-1.93-2.17-1.52-0.85-0.89-0.73-0.5-0.2
EBITDA 60.961-14.598-17.91-16.664-20.858-16.804-21.225-23.608-28.682-27.763-19.417-19.513-13.636-12.654-8.065-9.253-5.866-5.838-14.446-5.967-3.268-3.736-3.7-5.62-2.568-4.644-2.3231.234-4.765-2.02-4.268-1.709-1.927-1.314-0.697-0.731-0.272-0.2920
EBITDA Ratio 61.206-14.911-13.317-14.927-19.631-95.867-48.832-212.304-313.750-101.82-65.043-68.1800000000000000000000000000